Hyaluronan-based tissue substitutes are promising materials in cartilage reconstruction surgery. Herein, the chondrogenesis of human mesenchymal stem cells (MSC) in a hydrogel based on a tyramine derivative of hyaluronan crosslinked by hydrogen peroxidase (HA-TA) was evaluated. Human MSC seeded in the scaffold were incubated in standard chondrogenic medium and medium enriched with bone morphogenetic protein-6 (BMP6). Cell viability, the gene expression of selected markers (collagen type II, aggrecan, SOX9, collagen type X, and osteopontin), and the histological characteristics were examined during three weeks of in vitro cultivation. The tissue reaction of both unseeded and MSC seeded HA-TA scaffolds were tested in vivo after subcutaneous application in rats for 12 weeks. The data showed that cells resisted the process of crosslinking and remained viable for the whole time while exhibiting changes in cell organization. Human MSC cultivated in HA-TA hydrogel expressed genes of both chondrogenic and osteogenic differentiation and the addition of BMP6 revealed a tendency to potentiate both processes. Histological analysis of HA-TA in vivo implants did not reveal a chronic inflammatory reaction. In both cases, in vivo HA-TA implants were continuously degraded and MSC-seeded hydrogels tended to form clusters similar to in vitro samples. In conclusion, MSC chondrogenic differentiation may proceed in a HA-TA scaffold that is biocompatible. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 3523-3530, 2014.

Contipro Biotech s r o 401 561 02 Dolní Dobrouč Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc15023619

003      

CZ-PrNML

005      

20150724105533.0

007      

ta

008      

150709s2014 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1002/jbm.a.35033 $2 doi

035    __

$a (PubMed)24243864

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Dvořáková, Jana $u Contipro Biotech s.r.o., 401, 561 02, Dolní Dobrouč, Czech Republic.

245    10

$a Chondrogenic differentiation of mesenchymal stem cells in a hydrogel system based on an enzymatically crosslinked tyramine derivative of hyaluronan / $c J. Dvořáková, L. Kučera, J. Kučera, K. Švík, M. Foglarová, T. Muthný, M. Pravda, M. Němcová, V. Velebný, L. Kubala,

520    9_

$a Hyaluronan-based tissue substitutes are promising materials in cartilage reconstruction surgery. Herein, the chondrogenesis of human mesenchymal stem cells (MSC) in a hydrogel based on a tyramine derivative of hyaluronan crosslinked by hydrogen peroxidase (HA-TA) was evaluated. Human MSC seeded in the scaffold were incubated in standard chondrogenic medium and medium enriched with bone morphogenetic protein-6 (BMP6). Cell viability, the gene expression of selected markers (collagen type II, aggrecan, SOX9, collagen type X, and osteopontin), and the histological characteristics were examined during three weeks of in vitro cultivation. The tissue reaction of both unseeded and MSC seeded HA-TA scaffolds were tested in vivo after subcutaneous application in rats for 12 weeks. The data showed that cells resisted the process of crosslinking and remained viable for the whole time while exhibiting changes in cell organization. Human MSC cultivated in HA-TA hydrogel expressed genes of both chondrogenic and osteogenic differentiation and the addition of BMP6 revealed a tendency to potentiate both processes. Histological analysis of HA-TA in vivo implants did not reveal a chronic inflammatory reaction. In both cases, in vivo HA-TA implants were continuously degraded and MSC-seeded hydrogels tended to form clusters similar to in vitro samples. In conclusion, MSC chondrogenic differentiation may proceed in a HA-TA scaffold that is biocompatible. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 3523-3530, 2014.

650    _2

$a zvířata $7 D000818

650    12

$a buněčná diferenciace $x účinky léků $x genetika $7 D002454

650    _2

$a viabilita buněk $x účinky léků $7 D002470

650    _2

$a imobilizované buňky $x cytologie $x účinky léků $x metabolismus $7 D018914

650    12

$a chondrogeneze $x účinky léků $x genetika $7 D020219

650    _2

$a reagencia zkříženě vázaná $x farmakologie $7 D003432

650    _2

$a regulace genové exprese $x účinky léků $7 D005786

650    _2

$a lidé $7 D006801

650    _2

$a kyselina hyaluronová $x farmakologie $7 D006820

650    _2

$a PEG-DMA hydrogel $x farmakologie $7 D020136

650    _2

$a zobrazování trojrozměrné $7 D021621

650    _2

$a experimentální implantáty $7 D020007

650    _2

$a mezenchymální kmenové buňky $x cytologie $x účinky léků $x metabolismus $7 D059630

650    _2

$a peroxidasa $x metabolismus $7 D009195

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a subkutánní tkáň $x účinky léků $7 D040521

650    _2

$a tyramin $x farmakologie $7 D014439

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Kučera, Lukáš

700    1_

$a Kučera, Jan

700    1_

$a Švík, Karol

700    1_

$a Foglarová, Marcela

700    1_

$a Muthný, Tomáš

700    1_

$a Pravda, Martin

700    1_

$a Němcová, Miroslava

700    1_

$a Velebný, Vladimír

700    1_

$a Kubala, Lukáš

773    0_

$w MED00007498 $t Journal of biomedical materials research. Part A $x 1552-4965 $g Roč. 102, č. 10 (2014), s. 3523-30

856    41

$u https://pubmed.ncbi.nlm.nih.gov/24243864 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20150709 $b ABA008

991    __

$a 20150724105612 $b ABA008

999    __

$a ok $b bmc $g 1083956 $s 906612

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2014 $b 102 $c 10 $d 3523-30 $i 1552-4965 $m Journal of biomedical materials research. Part A $n J Biomed Mater Res $x MED00007498

LZP    __

$a Pubmed-20150709